Grow with the world’s untapped science

Partner for the future of scientific capital markets

We are seeking qualified partners for the road ahead

Capital Partners

Family offices, funds, sovereign and strategic capital.

Innovation Partners

AI partners, CROs, CDMOs, research labs.

Infrastructure Partners

Issuance, custody, compliance, transfer, market infrastructure.

Asset Partners

Biotech, pharma, universities, research institutes.

BioVergence works with capital providers,infrastructure partners, innovators, and asset owners to build a repeatable market for scientific assets.

Expert, patient, builder, and capital communities help source and validate opportunities.

BioVergence

Scientific capital markets

Structured digital securities,

Asset-level financing

Standalone pipeline projects

Yield Strategies

Royalties

Milestones

Revenue participation

Growth Strategies

Full-program tokens

Biosimilars

Moonshots

Institutional Strategies

Structured credit

Portfolio vehicles

Sovereign co-investment

Why partner

For Assets

Surface hidden value

Reveal intrinsic value in IP, data, royalties, and development programs.

Asset-specific financing

Tailored structures that reflect unique risk/return profiles.

Broader investor reach

Institutional and strategic capital partners aligned to the asset.

Retain control

Economic exposure can be separated from operational control.

BioVergence’s global network

Our model combines structured financing, partner-led execution, and AI-enabled diligence so high- value science can reach the rightcapital and strategic counterparties.
‍
We’re dedicated to a unique, vetted, regulated, and partnered ecosystem.

About Us